SCHEMBL4972085

SCHEMBL4972085

O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nc4ccccc4n3)CC2)s1)c1ccc(Cl)cc1.O=C(NCc1ccc(S(=O)(=O)N2CCN(c3ccc(Cl)cc3)CC2)s1)c1ccc(Cl)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 1/20 0.68
MAPK10 P53779 1/20 0.68
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
BCL2 P10415 2/20 0.51
BCL2L1 Q07817 2/20 0.51
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HTT P42858 1/20 0.46
MAPT P10636 5/20 0.42
THRB P10828 1/20 0.42
POLB P06746 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
EPHX2 P34913 1/20 0.38
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2422850 0.94 MAPK9 (0.75) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL7886289 0.88 MAPK9 (0.65) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2423054 0.86 MAPK9 (0.59) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2424858 0.85 MAPK9 (0.61) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2420939 0.85 MAPK9 (0.63) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2425309 0.83 MAPK9 (0.60) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2420008 0.83 MAPK9 (0.68) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2428129 0.83 MAPK9 (0.56) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL6436945 0.82 MAPK9 (0.59) MAPK9MAPK10MEN1KMT2ABCL2
SCHEMBL2422491 0.82 MAPT (0.58) MAPK9MAPK10MEN1KMT2ABCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904181-A2 JNK INHIBITORS FOR THE TREATMENT OF ENDOMETREOSIS LABORATOIRES SERONO S.A. (CH) 2008-04-02 EP disclosed
WO-2007011762-A2 JNK INHIBITORS FOR THE TREATMENT OF ENDOMETREOSIS LABORATOIRES SERONO S.A. (CH) 2007-01-25 WO disclosed
EP-1218374-A1 PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES Applied Research Systems ARS Holding N.V. (AN) 2002-07-03 EP disclosed
WO-2001023378-A1 PHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO disclosed